Agios Pharmaceuticals (AGIO) Inventory Average (2018 - 2026)

Agios Pharmaceuticals has reported Inventory Average for 8 years, with the latest figure at $34.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 18.85% year-over-year to $34.0 million; the trailing twelve-month figure through Mar 2026 stood at $34.0 million (up 18.85% YoY), and the FY2025 full-year result was $30.3 million, up 29.65% from the prior year.
• Inventory Average for Q1 2026 stood at $34.0 million, up from $32.5 million in the prior quarter.
• The five-year high for Inventory Average was $34.0 million in Q1 2026, with the low at $3.3 million in Q2 2022.
• Historically, Inventory Average has averaged $20.4 million across 5 years, with a median of $22.3 million in 2024.
• Annual changes were most pronounced in 2023 — Inventory Average soared 313.22% — and 2026, when it climbed 18.85%.
• Agios Pharmaceuticals' Inventory Average stood at $6.8 million in 2022, then surged by 165.95% to $18.2 million in 2023, then jumped by 48.68% to $27.0 million in 2024, then gained by 20.19% to $32.5 million in 2025, then climbed by 4.7% to $34.0 million in 2026.
• The last three Inventory Average figures came in at $34.0 million (Q1 2026), $32.5 million (Q4 2025), and $31.4 million (Q3 2025), per Business Quant data.